Total Payments
$971.53
2024 Payments
$204.59
Companies
10
Transactions
22
Medicare Patients
2,015
Medicare Billing
$293,845
Payment Breakdown by Category
Food & Beverage$954.63 (98.3%)
Education$16.90 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $954.63 | 20 | 98.3% |
| Education | $16.90 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $188.12 | 5 | $0 (2017) |
| Theravance Biopharma Inc. | $171.70 | 4 | $0 (2017) |
| ABBVIE INC. | $136.30 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $115.83 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $115.69 | 1 | $0 (2017) |
| Boston Scientific Corporation | $107.43 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $54.99 | 3 | $0 (2017) |
| ABIOMED | $41.62 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $26.67 | 1 | $0 (2024) |
| PFIZER INC. | $13.18 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.59 | 6 | ABBVIE INC. ($136.30) |
| 2022 | $13.18 | 1 | PFIZER INC. ($13.18) |
| 2019 | $107.43 | 1 | Boston Scientific Corporation ($107.43) |
| 2017 | $646.33 | 14 | Allergan Inc. ($188.12) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| 10/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $69.68 | General |
| 07/08/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 07/08/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 02/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $49.72 | General |
| 01/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $41.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $107.43 | General |
| Category: STRUCTURAL HEART | ||||||
| 12/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/20/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/06/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Infectious Disease | ||||||
| 08/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $115.69 | General |
| Category: Cardiovascular | ||||||
| 08/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/22/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Infectious Disease | ||||||
| 08/21/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Infectious Disease | ||||||
| 07/31/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/22/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $124.93 | General |
| Category: Infectious Disease | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 646 | 2,044 | $749,050 | $98,521 |
| 2022 | 7 | 390 | 624 | $118,443 | $55,604 |
| 2021 | 8 | 470 | 670 | $124,452 | $66,181 |
| 2020 | 7 | 509 | 744 | $139,169 | $73,540 |
Total Patients
2,015
Total Services
4,082
Medicare Billing
$293,845
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 127 | 782 | $273,700 | $28,479 | 10.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 158 | 596 | $238,400 | $26,820 | 11.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 128 | 159 | $47,750 | $18,900 | 39.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 103 | 377 | $150,800 | $18,214 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $8,300 | $3,077 | 37.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $6,400 | $1,525 | 23.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 79 | 79 | $23,700 | $1,506 | 6.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 153 | 369 | $65,136 | $30,782 | 47.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 147 | 164 | $31,632 | $14,356 | 45.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $8,290 | $3,753 | 45.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,014 | $2,014 | 100.0% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 13 | 13 | $4,734 | $1,801 | 38.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 27 | 28 | $3,857 | $1,710 | 44.3% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 15 | 15 | $2,782 | $1,188 | 42.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 182 | 361 | $59,475 | $31,988 | 53.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 138 | 145 | $24,759 | $13,203 | 53.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 52 | $16,900 | $8,849 | 52.4% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2021 | 27 | 30 | $10,388 | $5,232 | 50.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 16 | 16 | $4,708 | $2,592 | 55.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 35 | $3,999 | $2,281 | 57.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 18 | 18 | $2,079 | $1,163 | 55.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $2,145 | $873.20 | 40.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 212 | 424 | $69,854 | $37,332 | 53.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 147 | 168 | $28,686 | $15,289 | 53.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 53 | 54 | $17,550 | $9,393 | 53.5% |
About Dr. Jonathan Martinez Dalmasi, M.D
Dr. Jonathan Martinez Dalmasi, M.D is a Internal Medicine healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2014. The National Provider Identifier (NPI) number assigned to this provider is 1881093409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Martinez Dalmasi, M.D has received a total of $971.53 in payments from pharmaceutical and medical device companies, with $204.59 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($954.63).
As a Medicare-enrolled provider, Martinez Dalmasi has provided services to 2,015 Medicare beneficiaries, totaling 4,082 services with total Medicare billing of $293,845. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Stratford, NJ
- Active Since 08/19/2014
- Last Updated 01/03/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881093409
Products in Payments
- VIBATIV (Drug) $171.70
- ELIQUIS (Drug) $128.87
- AVYCAZ (Drug) $124.94
- XARELTO (Drug) $115.83
- WATCHMAN (Device) $107.43
- TEFLARO (Drug) $63.18
- JANUVIA (Drug) $54.99
- Impella (Device) $41.62
- DYSPORT (Biological) $26.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stratford
Dr. Edward Carreras, M.d, M.D
Internal Medicine — Payments: $27,269
Internal Medicine $27,269
Dr. Lucia Chou, M.d, M.D
Internal Medicine — Payments: $21,643
Internal Medicine $21,643
Panayotes Yannopoulos, Md, MD
Internal Medicine — Payments: $17,274
Internal Medicine $17,274
Dr. Bobby Malik, Md, MD
Internal Medicine — Payments: $11,929
Internal Medicine $11,929
Leonid Karkanitsa, Md, MD
Internal Medicine — Payments: $8,720
Internal Medicine $8,720
Dr. Magdala Chery, D.o, D.O
Internal Medicine — Payments: $6,644
Internal Medicine $6,644